EP 1653966 A1 20060510 - TREATMENT OF SEXUAL DYSFUNCTION
Title (en)
TREATMENT OF SEXUAL DYSFUNCTION
Title (de)
BEHANDLUNG DER SEXUELLEN DYSFUNKTION
Title (fr)
TRAITEMENT DES DYSFONCTIONNEMENTS SEXUELS
Publication
Application
Priority
- IB 2004002286 W 20040712
- GB 0316673 A 20030716
- GB 0318095 A 20030801
- GB 0321308 A 20030911
Abstract (en)
[origin: WO2005007166A1] This invention relates to the use of cyclic guanosine 3', 5'-monophosphate phosphodiesterase type five (PDE5) inhibitors, in combination with 5HT1a agonists for the treatment of sexual dysfunction, particularly female sexual arousal disorder (FSAD) with concomitant hypoactive sexual desire disorder (HSDD).
IPC 1-7
A61K 31/519; A61K 31/635; A61K 31/496; A61K 31/00; A61P 15/00
IPC 8 full level
A61K 31/496 (2006.01); A61K 31/519 (2006.01); A61K 31/635 (2006.01); A61K 45/06 (2006.01); A61P 15/00 (2006.01)
CPC (source: EP)
A61K 31/496 (2013.01); A61K 31/519 (2013.01); A61K 31/635 (2013.01); A61K 45/06 (2013.01); A61P 15/00 (2017.12); A61P 15/08 (2017.12); A61P 15/10 (2017.12)
C-Set (source: EP)
Citation (search report)
See references of WO 2005007166A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005007166 A1 20050127; BR PI0411985 A 20060829; CA 2532252 A1 20050127; EP 1653966 A1 20060510; JP 2007516949 A 20070628; MX PA06000623 A 20060411; TW 200505410 A 20050216
DOCDB simple family (application)
IB 2004002286 W 20040712; BR PI0411985 A 20040712; CA 2532252 A 20040712; EP 04743948 A 20040712; JP 2006520035 A 20040712; MX PA06000623 A 20040712; TW 93121146 A 20040715